CymaBay Therapeutics, Inc. 4
4 · CymaBay Therapeutics, Inc. · Filed Jan 6, 2017
Insider Transaction Report
Form 4
Boudes Pol F
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2017-01-04+21,000→ 42,000 totalExercise: $1.82From: 2017-01-04Exp: 2026-07-24→ Common Stock (21,000 underlying)
Footnotes (1)
- [F1]On July 25, 2016, the Reporting Person was granted an option to purchase 42,000 shares of common stock of the Issuer. The option vests in two equal installments based on the Issuer's achieving certain milestones. The first milestone was met on December 30, 2016, resulting in vesting of the option as to 21,000 shares, which was reported on a prior Form 4. The second milestone was met on January 4, 2017, resulting in vesting of the option as to the remaining 21,000 shares.